G42 Investments AI Holdings RSC Ltd. - 31 May 2022 Form 3 Insider Report for vTv Therapeutics Inc. (VTVT)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: VTVT
Reported as of: 31 May 2022
Net transaction value: $0
SEC form: 3
Accepted by SEC: 10 Jun 2022, 20:31:09 UTC
Source filing: View source filing
Reporting owner signature: /s/ Martin Edelman, Director of G42 Investments AI Holding RSC Ltd.

Key filing fact

G42 Investments AI Holdings RSC Ltd. filed Form 3 for vTv Therapeutics Inc. (VTVT) on 10 Jun 2022.

Key facts

This page summarizes G42 Investments AI Holdings RSC Ltd.'s Form 3 filing for vTv Therapeutics Inc. (VTVT).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 10 Jun 2022, 20:31.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VTVT holding

Class A Common Stock ("Common Stock")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,386,274
Date: 31 May 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Common Stock is held directly by G42 Investments AI Holding RSC Ltd ("G42 Investments"). G42 Investments is a wholly-owned subsidiary of Group 42 Holding Ltd, registered office at Office 801, Floor 8, Al Khatem Tower, ADGM, Al Maryah, Abu Dhabi, United Arab Emirates ("Group 42"). Group 42 is controlled by its majority shareholder RGH1 Investment SPV RSC Ltd, registered office at Office 2458, Floor 24, Al Sila Tower, ADGM, Al Maryah, Abu Dhabi, United Arab Emirates ("Royal Group"). HH Sheikh Tahnoon Bin Zayed S. Al-Nahyan is the ultimate beneficial owner of Royal Group.

SEC remarks

Dr. Marzooqi is a director of the Issuer. As a result, the following persons may be deemed directors by deputization of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended: G42 Investments.